New
With total funding now at $6 million, Revisto is poised to transform the life sciences industry's tedious and costly approach to marketing compliance.
Revisto provides specific and actionable recommendations by understanding your company's and brand's unique data.
Save over $15m annually with Revisto
Request a demo today to discover how you can streamline your content creation process
Save time and money, identify drug-related content issues early, and expedite reviews of all your pharma marketing materials using our AI-driven platform.
Reduce your time to market
Drug manufacturers lose millions of dollars annually due to pharma marketing material release delays. Our AI platform speeds up MLR reviews and gives valuable time back to writers, designers, and SMEs.
Maintain high quality standards
Revisto evaluates marketing content for quality, consistency, and accuracy and provides feedback to creative teams before they even submit materials for MLR review.
Save your team hours
With Revisto, the days of dealing with hard-to-track feedback, many rounds of updates, and human error are over. Our user-friendly solution provides timely content and supports efficient collaboration.
